AmerisourceBergen Co. (NYSE:ABC) saw unusually large options trading on Thursday. Stock traders acquired 5,457 call options on the company. This is an increase of approximately 861% compared to the average daily volume of 568 call options.
A number of analysts have recently issued reports on the company. Scotiabank lowered AmerisourceBergen from an “outperform” rating to a “sector perform” rating in a research note on Thursday, January 6th. Robert W. Baird upped their target price on shares of AmerisourceBergen from $175.00 to $179.00 in a report on Thursday, February 3rd. Morgan Stanley increased their target price on shares of AmerisourceBergen from $141.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, December 17th. Credit Suisse Group boosted their price target on shares of AmerisourceBergen from $144.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, November 8th. Finally, Mizuho increased their price objective on shares of AmerisourceBergen from $130.00 to $139.00 and gave the company a “neutral” rating in a report on Thursday, February 3rd. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $151.67.
In other news, CEO Steven H. Collis sold 24,263 shares of AmerisourceBergen stock in a transaction dated Tuesday, February 8th. The shares were sold at an average price of $141.22, for a total value of $3,426,420.86. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Robert P. Mauch sold 44,492 shares of the business’s stock in a transaction dated Tuesday, February 1st. The stock was sold at an average price of $137.04, for a total transaction of $6,097,183.68. The disclosure for this sale can be found here. Insiders sold a total of 171,802 shares of company stock valued at $22,954,653 in the last ninety days. 28.40% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ABC. Geode Capital Management LLC boosted its position in shares of AmerisourceBergen by 4.3% during the 4th quarter. Geode Capital Management LLC now owns 2,735,360 shares of the company’s stock worth $362,726,000 after purchasing an additional 113,699 shares during the period. Gabelli Funds LLC boosted its position in shares of AmerisourceBergen by 3.6% during the fourth quarter. Gabelli Funds LLC now owns 142,000 shares of the company’s stock worth $18,870,000 after buying an additional 5,000 shares during the period. United Bank acquired a new stake in shares of AmerisourceBergen in the fourth quarter valued at $414,000. Laraway Financial Inc acquired a new stake in shares of AmerisourceBergen in the fourth quarter valued at $505,000. Finally, Financial Advisors Network Inc. raised its holdings in shares of AmerisourceBergen by 3.8% in the 4th quarter. Financial Advisors Network Inc. now owns 21,908 shares of the company’s stock valued at $2,911,000 after buying an additional 810 shares during the period. Institutional investors and hedge funds own 62.99% of the company’s stock.
AmerisourceBergen stock opened at $140.24 on Friday. The company has a current ratio of 0.95, a quick ratio of 0.57 and a debt-to-equity ratio of 10.67. The company has a 50-day moving average price of $131.76 and a 200 day moving average price of $125.19. AmerisourceBergen has a 12-month low of $100.71 and a 12-month high of $143.61. The stock has a market cap of $29.19 billion, a P/E ratio of 18.19, a PEG ratio of 1.56 and a beta of 0.48.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings results on Wednesday, February 2nd. The company reported $2.58 earnings per share for the quarter, meeting the consensus estimate of $2.58. The business had revenue of $59.63 billion during the quarter, compared to analysts’ expectations of $59.62 billion. AmerisourceBergen had a net margin of 0.73% and a return on equity of 543.21%. The business’s revenue for the quarter was up 13.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.18 EPS. As a group, analysts forecast that AmerisourceBergen will post 10.75 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, February 28th. Shareholders of record on Monday, February 14th will be given a $0.46 dividend. The ex-dividend date of this dividend is Friday, February 11th. This represents a $1.84 dividend on an annualized basis and a yield of 1.31%. AmerisourceBergen’s dividend payout ratio is currently 23.87%.
AmerisourceBergen Company Profile
AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies.
Want More Great Investing Ideas?